Is continuous restraint and sleep deprivation harmful for an ICU patient when physicians withhold sleep‑promoting medications to satisfy hourly NIHHS (National Institute for Health and Human Services) assessments for more than 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, continuous restraint and sleep deprivation for >24 hours to facilitate hourly NIHSS assessments is harmful and represents suboptimal care that should be modified.

This practice creates a cascade of harm: sleep deprivation contributes to ICU delirium, prolonged mechanical ventilation, immune dysfunction, and neurocognitive impairment, while physical restraints compound these risks and impose significant moral distress on caregivers without clear evidence of benefit 1.

The Evidence Against This Practice

Sleep Deprivation Harms in the ICU

Sleep disruption in critically ill patients is severe and well-documented to cause:

  • ICU delirium (a direct contributor) 1
  • Prolonged mechanical ventilation 2
  • Deranged immune function 1
  • Neurocognitive dysfunction 1
  • Increased cardiovascular disease risk and mortality 2

The 2018 Critical Care Medicine guidelines explicitly state that sleep deprivation is hypothesized to contribute to these adverse outcomes 1. Sleep disruption affects 47-60% of ICU patients and often persists after discharge, contributing to prolonged recovery and higher mortality 3.

Physical Restraint Concerns

Recent high-quality evidence, particularly the R2D2-ICU trial, challenges the assumption that restraints improve safety 4. Physical restraints are associated with:

  • Negative physical, neurological, and psychological outcomes 4
  • Heavy moral distress burden on caregivers 4
  • Questionable effectiveness for preventing tube removal 4
  • Increasing use over time (36.9% in 2008-2010 to 44.0% in 2020-2022) despite uncertain clinical benefit 5

Restraints should be viewed as a potentially harmful intervention of last resort, not a standard safety tool 4.

The Clinical Solution: Modify Assessment Frequency

For Stroke Patients Requiring Neurological Monitoring

The key issue is that hourly NIHSS assessments beyond 24 hours are rarely clinically necessary for most stroke patients. Standard stroke protocols typically require:

  • First 24 hours: Hourly assessments are appropriate for acute stroke patients, particularly those who received thrombolytics or thrombectomy
  • After 24 hours: If the patient is stable, assessments can be spaced to every 2-4 hours, allowing consolidated sleep periods

The clinical team should reassess whether continued hourly monitoring is truly indicated or has become reflexive practice. Most neurological deterioration occurs in the first 24 hours; continuing hourly assessments beyond this without specific indication prioritizes documentation over patient welfare.

Recommended Interventions

1. Implement a Sleep-Promoting Protocol

The 2018 guidelines suggest using multicomponent sleep-promoting protocols 1. These should include:

  • Earplugs and eyeshades (patient choice to use/discontinue) 1
  • Clustering care activities to create 4-hour uninterrupted sleep blocks 6
  • Noise and light control at night 6
  • Relaxing music (shown to improve self-reported sleep quality) 1

Pooled analysis demonstrates these protocols reduce delirium prevalence (RR 0.62,95% CI 0.42-0.91) 7 and can reduce delirium incidence by 30-50% while shortening ICU stays by approximately 1.2 days 3.

2. Consider Pharmacologic Sleep Support

If non-pharmacologic measures fail and the patient requires sedation:

Dexmedetomidine is the preferred agent 2, 1:

  • Preserves circadian rhythm (79% of sleep occurs at night vs 48% with placebo) 2
  • Improves sleep efficiency and decreases fragmentation 2
  • Does not suppress REM sleep like benzodiazepines or propofol 2
  • The 2018 guidelines make no formal recommendation for dexmedetomidine specifically for sleep (low quality evidence), but note it may be reasonable if sedation is indicated overnight 1

Avoid:

  • Propofol: Suppresses REM sleep, causes hemodynamic/respiratory depression 1, 7
  • Benzodiazepines: Alter sleep architecture, increase delirium risk 2, 6

3. Minimize Restraint Use

Successful restraint minimization requires multicomponent approaches 4:

  • Reassess restraint necessity every shift
  • Address underlying causes of agitation (pain, delirium, sleep deprivation)
  • Use alternative strategies: reorientation, family presence, environmental modification
  • Consider that the restraints themselves may be perpetuating the agitation-restraint cycle

Common Pitfalls to Avoid

  1. Reflexive continuation of hourly assessments: Question whether this frequency remains clinically indicated after 24 hours
  2. Assuming restraints prevent harm: Evidence suggests they may cause more harm than they prevent 4
  3. Using propofol or benzodiazepines for sleep: These suppress restorative sleep stages 2, 1
  4. Ignoring the sleep-delirium connection: Sleep deprivation directly contributes to delirium, which then prompts more restraints—a vicious cycle 1

The Bottom Line

Modify the assessment frequency after 24 hours to allow consolidated sleep periods (minimum 4-hour blocks), implement a multicomponent sleep-promoting protocol, and minimize restraint use. The current practice prioritizes documentation compliance over patient outcomes. If neurological monitoring remains essential, consider spacing assessments to every 2-4 hours after the initial 24-hour period, which still allows detection of clinically significant changes while permitting restorative sleep 1, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.